Pieris Pharmaceuticals (NASDAQ:PIRS) Now Covered by Analysts at StockNews.com
StockNews.com began coverage on shares of Pieris Pharmaceuticals (NASDAQ:PIRS – Free Report) in a research report sent to investors on Wednesday. The brokerage issued a hold rating on the biotechnology company’s stock. Pieris Pharmaceuticals Price Performance Shares of Pieris Pharmaceuticals stock opened at $9.81 on Wednesday. The business’s fifty day moving average price is $10.50 […]
More Stories
Is Rosario Tijeras Season 5 Renewed? Release Date, Cast, and Synopsis
The popular Mexican television series or opera drama, Rosario Tijeras, is returning for its 5th season after getting a positive...
Pokémon Horizons Season 3: Release Date, Trailer, and Spoiler
Fan of the Pokémon series and desperately waiting for its release? Good News! Pokémon Horizons Season 3 is coming up...
Drew Carey Blast on Mayor Candidate, Spencer Pratt, called him a ‘Serial Scammer’
Drew Carey, a popular host, actor, and producer, has slammed the Los Angeles mayoral candidate, Spencer Pratt. On May 24,...
15+ Best Thrillers on Netflix: Movies and Television Series
Do you love to watch thriller shows and movies? Here, in this blog, I have mentioned the best thrillers on...
Maternal Instinct: A True Crime Documentary will release on Netflix this June
Do you also like true crime documentaries like The Investigation of Lucy Letby and Should I Marry a Murderer? Good...
You Can’t Skip These Roblox Competitors
Roblox has introduced millions of joystick junkies and developers to the world for creating amazing games and igniting their creative...